+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Pyrogen Testing Market by Product Type, Test Type, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4968889
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Pyrogen Testing Market grew from USD 1.24 billion in 2023 to USD 1.38 billion in 2024. It is expected to continue growing at a CAGR of 11.64%, reaching USD 2.68 billion by 2030.

Pyrogen testing is a crucial quality control process in the pharmaceutical and biotechnology industries, focusing on detecting pyrogens, or fever-inducing contaminants, in drugs and medical devices. The necessity of pyrogen testing arises from the need to ensure patient safety, as pyrogens can cause severe reactions when introduced into the bloodstream. The primary application of pyrogen testing is in the production and validation of sterile pharmaceuticals, biologics, and implantable medical devices, which highlights its end-use scope across hospitals, research labs, and pharmaceutical companies. Key factors driving market growth include stringent regulatory guidelines, increasing pharmaceutical production, and heightened awareness regarding healthcare safety. However, challenges such as the high cost of testing methods, the complexity of detecting endotoxins, and evolving regulatory landscapes can impede market expansion. Despite these challenges, opportunities abound in technological advancements, like the development of novel in-vitro testing methods, which promise more accurate and ethical alternatives to animal testing. For business growth, companies could focus on investing in research to develop cost-effective, rapid microbiological methods and automated testing solutions. Opportunities also lie in expanding testing services in emerging markets where pharmaceutical manufacturing is burgeoning. However, regulatory compliance remains a critical challenge, and businesses must stay abreast of international standards like those from the FDA and EMA. Innovation could also flourish in creating multiplex assays to detect a range of pyrogens simultaneously, reducing time and operational costs. Understanding the nature of this market, characterized by technological innovation and regulatory oversight, will be crucial to navigating the evolving landscape. For businesses looking to leverage these market dynamics, forming strategic collaborations with technology firms and engaging in detailed market intelligence could provide competitive advantages.

Understanding Market Dynamics in the Pyrogen Testing Market

The Pyrogen Testing Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising incidence of infectious and chronic diseases worldwide
    • Increasing production of pharmaceuticals, biologics, and medical device products
    • Stringent regulations and standards set by health authorities worldwide
  • Market Restraints
    • High cost associated with the advanced pyrogen testing methods
  • Market Opportunities
    • Technological advancements in pyrogen testing technologies
    • Collaboration between market vendors and pharma companies to expand the deployment of pyrogen testing methods
  • Market Challenges
    • Operational and ethical concerns associated with pyrogen testing

Exploring Porter’s Five Forces for the Pyrogen Testing Market

Porter’s Five Forces framework further strengthens the insights of the Pyrogen Testing Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Pyrogen Testing Market

External macro-environmental factors deeply influence the performance of the Pyrogen Testing Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Pyrogen Testing Market

The Pyrogen Testing Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Pyrogen Testing Market

The Pyrogen Testing Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Pyrogen Testing Market

The Pyrogen Testing Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pyrogen Testing Market, highlighting leading vendors and their innovative profiles. These include Accugen Laboratories, Inc., Almac Group, Associates of Cape Cod, Inc., bioMérieux SA, Charles River Laboratories International, Inc., Corning Incorporated, Creative Bioarray, Eurofins Scientific SE, FUJIFILM Holdings Corporation, Genscript Biotech Corporation, Hycult Biotechnology B.V., IDEXX Laboratories, Inc., Incell Corporation LLC, Indoor Biotechnologies, Inc., InvivoGen S.A.S., Laboratory Corporation of America Holdings, Lonza Group AG, Lucideon Limited, MAT BioTech B.V., Merck KGaA, Microcoat Biotechnologie GmbH, Minerva Biolabs GmbH, Nelson Laboratories, LLC by Sotera Health Company, North American Science Associates, LLC, Novo Nordisk A/S, Pacific Biolabs Inc., QIAGEN N.V., Solvias AG, Steris PLC, Thermo Fisher Scientific Inc., Veolia Environnement S.A., Waters Corporation, Wickham Micro Limited by Cormica Group, and WuXi AppTec Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Pyrogen Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product Type
    • Assays, Kits, & Reagents
    • Instruments
    • Services
  • Test Type
    • Limulus Amoebocyte Lysate
      • Chromogenic Tests
      • Gel Clot Tests
      • Turbidimetric Tests
    • Monocyte Activation Test
    • Rabbit Pyrogen Test
    • Recombinant Cascade Reagent
    • Recombinant Factor C
  • End-User
    • Biotechnology Companies
    • Medical Device Companies
    • Pharmaceutical Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of infectious and chronic diseases worldwide
5.1.1.2. Increasing production of pharmaceuticals, biologics, and medical device products
5.1.1.3. Stringent regulations and standards set by health authorities worldwide
5.1.2. Restraints
5.1.2.1. High cost associated with the advanced pyrogen testing methods
5.1.3. Opportunities
5.1.3.1. Technological advancements in pyrogen testing technologies
5.1.3.2. Collaboration between market vendors and pharma companies to expand the deployment of pyrogen testing methods
5.1.4. Challenges
5.1.4.1. Operational and ethical concerns associated with pyrogen testing
5.2. Market Segmentation Analysis
5.2.1. Product Type: Increasing need of assays, kits, & reagents to automate, facilitate, or enhance the testing processes
5.2.2. Test Type: Rising usage of the LAL test due to its high sensitivity and reliability
5.2.3. End-User: Burgeoning adoption of pyrogen testing across biotechnology companies
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Pyrogen Testing Market, by Product Type
6.1. Introduction
6.2. Assays, Kits, & Reagents
6.3. Instruments
6.4. Services
7. Pyrogen Testing Market, by Test Type
7.1. Introduction
7.2. Limulus Amoebocyte Lysate
7.2.1. Chromogenic Tests
7.2.2. Gel Clot Tests
7.2.3. Turbidimetric Tests
7.3. Monocyte Activation Test
7.4. Rabbit Pyrogen Test
7.5. Recombinant Cascade Reagent
7.6. Recombinant Factor C
8. Pyrogen Testing Market, by End-User
8.1. Introduction
8.2. Biotechnology Companies
8.3. Medical Device Companies
8.4. Pharmaceutical Companies
9. Americas Pyrogen Testing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Pyrogen Testing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Pyrogen Testing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. FUJIFILM and Predictive Oncology Partner to Improve Bacterial Endotoxin Testing
12.3.2. New Flexibility for Bacterial Endotoxin Testing in Pharmaceutical Waters with Recombinant Factor C
12.3.3. Charles River Laboratories Launches Endosafe Trillium rCR Cartridge for Efficient, Animal-Free Testing
12.3.4. Lonza Introduces Advanced Rapid MAT Systems
12.3.5. Wickham Micro Expands Bacterial Endotoxin Testing Facilities to Meet Rising Demand in Medical and Pharmaceutical Sectors
12.3.6. MiCAN Technologies Raises JPY 200 Million to Advance Animal-Free Pyrogen Testing with Innovative MylcMAT Product
12.3.7. Lonza Introduced the Nebula Absorbance Reader for Pyrogen and Endotoxin Testing in Quality Control Labs
12.3.8. New ISO Standard ISO 11737-3:2023 Enhances Guidelines for Bacterial Endotoxin Testing in Medical Products
12.4. Strategy Analysis & Recommendation
12.4.1. Novo Nordisk A/S
12.4.2. FUJIFILM Holdings Corporation
12.4.3. Waters Corporation
12.4.4. Merck KGaA
12.4.5. Charles River Laboratories International, Inc.
List of Figures
FIGURE 1. PYROGEN TESTING MARKET RESEARCH PROCESS
FIGURE 2. PYROGEN TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PYROGEN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. PYROGEN TESTING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. PYROGEN TESTING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. PYROGEN TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PYROGEN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. PYROGEN TESTING MARKET DYNAMICS
TABLE 7. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PYROGEN TESTING MARKET SIZE, BY ASSAYS, KITS, & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PYROGEN TESTING MARKET SIZE, BY MONOCYTE ACTIVATION TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PYROGEN TESTING MARKET SIZE, BY RABBIT PYROGEN TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT CASCADE REAGENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT FACTOR C, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PYROGEN TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PYROGEN TESTING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PYROGEN TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. CANADA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 39. CANADA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 40. CANADA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 41. CANADA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. MEXICO PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 43. MEXICO PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 44. MEXICO PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 45. MEXICO PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. CHINA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 61. CHINA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 62. CHINA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 63. CHINA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. INDIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 65. INDIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 66. INDIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 67. INDIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. JAPAN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. JAPAN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 74. JAPAN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 75. JAPAN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. THAILAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 97. THAILAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 98. THAILAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 99. THAILAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 109. DENMARK PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. DENMARK PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 111. DENMARK PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 112. DENMARK PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. EGYPT PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. EGYPT PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 115. EGYPT PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 116. EGYPT PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. FINLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. FINLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 119. FINLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 120. FINLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. FRANCE PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. FRANCE PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 123. FRANCE PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 124. FRANCE PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. GERMANY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. GERMANY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 127. GERMANY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 128. GERMANY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. ITALY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. ITALY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 135. ITALY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 136. ITALY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. NORWAY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. NORWAY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 147. NORWAY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 148. NORWAY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. POLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. POLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 151. POLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 152. POLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 153. QATAR PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. QATAR PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 155. QATAR PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 156. QATAR PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. SPAIN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. SPAIN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 171. SPAIN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 172. SPAIN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. TURKEY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 182. TURKEY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 183. TURKEY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 184. TURKEY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 193. PYROGEN TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 194. PYROGEN TESTING MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Pyrogen Testing market, which are profiled in this report, include:
  • Accugen Laboratories, Inc.
  • Almac Group
  • Associates of Cape Cod, Inc.
  • bioMérieux SA
  • Charles River Laboratories International, Inc.
  • Corning Incorporated
  • Creative Bioarray
  • Eurofins Scientific SE
  • FUJIFILM Holdings Corporation
  • Genscript Biotech Corporation
  • Hycult Biotechnology B.V.
  • IDEXX Laboratories, Inc.
  • Incell Corporation LLC
  • Indoor Biotechnologies, Inc.
  • InvivoGen S.A.S.
  • Laboratory Corporation of America Holdings
  • Lonza Group AG
  • Lucideon Limited
  • MAT BioTech B.V.
  • Merck KGaA
  • Microcoat Biotechnologie GmbH
  • Minerva Biolabs GmbH
  • Nelson Laboratories, LLC by Sotera Health Company
  • North American Science Associates, LLC
  • Novo Nordisk A/S
  • Pacific Biolabs Inc.
  • QIAGEN N.V.
  • Solvias AG
  • Steris PLC
  • Thermo Fisher Scientific Inc.
  • Veolia Environnement S.A.
  • Waters Corporation
  • Wickham Micro Limited by Cormica Group
  • WuXi AppTec Co., Ltd.

Methodology

Loading
LOADING...

Table Information